Thermo Fisher Scientific Inc. Share Price Buenos Aires S.E.
Equities
TMOD
ARBCOM4601F7
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27 USD | -.--% | -.--% | -.--% |
10/05 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
10/05 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 4.3TCr 3,58700Cr | Sales 2025 * | 4.61TCr 3,84300Cr | Capitalization | 23TCr 19,07200Cr |
---|---|---|---|---|---|
Net income 2024 * | 614.6Cr 51TCr | Net income 2025 * | 697.1Cr 58TCr | EV / Sales 2024 * | 5.87 x |
Net Debt 2024 * | 2.4TCr 2,00100Cr | Net Debt 2025 * | 1.92TCr 1,60000Cr | EV / Sales 2025 * | 5.38 x |
P/E ratio 2024 * |
37.7
x | P/E ratio 2025 * |
32.3
x | Employees | 1,22,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Director of Finance/CFO | 57 | 01/01/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
C. Harris
BRD | Director/Board Member | 67 | 30/12/30 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01/22/01 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.88% | 19TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+1.67% | 6.41TCr | |
+18.24% | 5.21TCr | |
+7.04% | 5.19TCr | |
+10.83% | 4.43TCr | |
+5.94% | 3.68TCr | |
+28.26% | 3.17TCr |
- Stock Market
- Equities
- TMO Stock
- TMOD Stock